Cartography Biosciences has secured a strategic investment from the Samsung Life Science Fund, marking its first external funding round. This capital will advance the company's oncology pipeline and expand its drug discovery platform. The Samsung Life Science Fund is backed by Samsung Biologics, Samsung Bioepis, and Samsung C&T.
